Cyclic heptapeptide raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2025-08-30. Anything still debated is marked as such rather than presented as settled.
Bremelanotide acts as a non-selective agonist at melanocortin receptors, with reported activity at MC1R, MC3R, MC4R and MC5R. The proposed basis for its central effects is activation of MC4R populations in the hypothalamus, a region associated with appetite and reproductive signalling. Because the peptide carries a net positive charge and polar side chains, it does not cross biological membranes freely, which is one reason oral administration is not the standard route. Effects generally appear within an hour of parenteral administration and are described as centrally mediated rather than peripheral.
Bremelanotide, developed under the code PT-141, is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone. Its structure is Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH, with a lactam bridge joining the aspartate and lysine side chains. The molecule has the formula C50H68N14O10 and a monoisotopic mass near 1025 daltons. It is commonly prepared as the acetate salt and appears as a white to off-white lyophilised powder in solid form. The free acid is the pharmacologically relevant species, while the counter-ion improves handling and dissolution.
Development began with intranasal formulations investigated for erectile dysfunction, but blood pressure elevation limited that route and prompted a switch to subcutaneous delivery. Clinical testing then shifted toward hypoactive sexual desire disorder in premenopausal women, and a subcutaneous product received United States approval in 2019. Later trials examined other populations with mixed results, and questions about effect size, durability and patient selection remain open in the peer-reviewed literature. Research interest continues in parallel with the broader melanocortin field, where several synthetic analogues are studied together.
PT-141 is the research code for bremelanotide, a cyclic heptapeptide derived from alpha-melanocyte-stimulating hormone. The molecule belongs to the melanocortin receptor agonist family and shows highest affinity for the MC4 receptor subtype, with weaker activity at MC1, MC3 and MC5. Its structure retains the core His-Phe-Arg-Trp sequence that defines melanocortin recognition, while cyclization and terminal modifications improve metabolic stability relative to the parent hormone. Early work classified the compound as a centrally acting agent rather than a peripherally acting vasodilator, which shaped subsequent development priorities.
Receptor activation in hypothalamic and limbic circuits is the mechanism most often cited for the observed effects on sexual desire. Signalling through MC4R couples to Gs proteins and raises intracellular cyclic AMP, which in turn modulates dopaminergic tone in reward-related pathways. Because the peptide reaches the central nervous system after subcutaneous administration, peripheral vascular changes are regarded as secondary rather than primary. The precise neural circuits that translate receptor occupancy into behavioural change remain incompletely mapped, and published accounts describe the pathway in general terms rather than as a fully resolved sequence.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Cyclic heptapeptide | Synthetic analogue of alpha-MSH |
| Molecular formula | C50H68N14O10 | Acetate salt form commonly reported |
| Molecular mass | ~1025 Da | Monoisotopic value near 1025.2 |
| Key structural motif | Lactam bridge | Asp side chain to Lys side chain |
| Solid appearance | White to off-white powder | Lyophilised and hygroscopic |
Bremelanotide is a cyclic heptapeptide that binds several melanocortin receptors rather than one. In vitro assays report agonist activity at MC1R, MC3R, MC4R and MC5R, with MC4R generally treated as the subtype most relevant to sexual effects. MC4R is expressed in hypothalamic nuclei involved in appetite, energy balance and motivated behaviour, which provides a plausible route for central action. Selective MC4R agonists studied in animals produce comparable behavioural changes, supporting that interpretation.
How receptor activation translates into a change in desire is not established in detail. Proposed steps include modulation of dopaminergic signalling in reward circuits and downstream effects on autonomic tone. Human data consist mainly of clinical trials measuring self-reported outcomes rather than direct measurements of brain activity or transmitter release. The transient rise in blood pressure sometimes observed after administration is likewise reported consistently but explained only partly by known melanocortin pathways.
Melanocortin receptors form a family of five G-protein-coupled proteins, labelled MC1R through MC5R, that respond to peptides derived from pro-opiomelanocortin. Alpha-melanocyte-stimulating hormone and adrenocorticotropic hormone are the best-known endogenous ligands. The receptors are distributed differently across tissues, so a single agonist can produce effects in the brain, skin, adrenal gland and vasculature. This distribution explains why one peptide can influence both pigmentation and motivated behaviour.
Identity and purity testing for this peptide typically relies on reversed-phase high-performance liquid chromatography with ultraviolet detection, reported as area-percent purity. Mass spectrometry, usually in tandem mode, confirms molecular mass and supports quantification in biological matrices. Sequence confirmation may use peptide mapping after enzymatic digestion, while nuclear magnetic resonance and circular dichroism supply supplementary structural detail. No single technique establishes identity alone, so laboratories compare retention time, mass, and fragment pattern against a verified reference standard.
The lactam ring that closes the peptide backbone improves resistance to exopeptidase attack, but the molecule stays susceptible to hydrolysis and oxidation once dissolved. Degradation accelerates with temperature, extreme pH, and light exposure, and repeated freeze-thaw cycles promote aggregation and material loss. Lyophilized powder held desiccated at or below minus twenty degrees Celsius is the common way to keep reference material. Reconstituted solutions are generally kept cold and used within a short window because their stability is far lower than that of the dry solid.
Bremelanotide is a moderately large peptide with a molecular mass near 1025 daltons. In lyophilised form it appears as a white to off-white powder and is freely soluble in water and other polar solvents. The intact lactam ring is essential for receptor affinity, while linearised fragments bind far more weakly. Solutions are sensitive to extremes of pH and to prolonged exposure to light and heat, so handling typically involves buffered conditions and cold storage. Its short plasma half-life reflects rapid distribution and clearance rather than chemical breakdown inside the vial.
Development of the peptide passed through several delivery formats, including an intranasal version tested in early trials and an injectable version that entered later clinical study. Regulatory approval for a subcutaneous product in the United States was granted in 2019 after review of controlled trials in premenopausal women. Outside the clinic, the compound circulates in research and non-pharmaceutical markets under its code name, where identity and purity vary considerably between suppliers. Synonyms appearing across technical literature include bremelanotide, PT-141, and Palatin 141.
PT-141 is the research designation for bremelanotide, a synthetic cyclic heptapeptide developed as a melanocortin receptor agonist. The peptide contains seven amino acids with an internal lactam bridge that constrains the backbone into a stable ring. Cyclisation of this kind improves resistance to enzymatic degradation relative to linear analogues. The compound was first explored for effects on melanin production, because several melanocortin receptors influence pigmentation. Its later association with sexual desire emerged from observations made during that early work, and the molecule became the subject of a separate development programme.
== History == Efficacy was evaluated in HERIZON-BTC-01 (NCT04466891), an open-label multicenter, single-arm trial in 62 participants with unresectable or metastatic HER2-positive (IHC3+) biliary tract cancer. Participants were required to have received at least one prior gemcitabine-containing regimen in the advanced disease setting. The US Food and Drug Administration (FDA) granted the application for zanidatamab priority review, breakthrough therapy, and orphan drug designations.
During the War against the Peru-Bolivian Confederation, relations between the Peru-Bolivian Confederation and the Argentine Confederation had deteriorated, among other reasons due to Bolivian President Andrés de Santa Cruz's support for unitary groups that had carried out at least four incursions since the southern Bolivia to the northern Argentine provinces in the years before the war. This led to anti-Peruvian measures on the part of the Argentine Government, such as that of February 13, 1837, where Rosas declared closed all commercial, epistolary and any kind of communication between the inhabitants of the Argentine Confederation and those of Peru and Bolivia, declaring " traitor to the country" to anyone who crossed the border into those countries. Both confederations did not have formal diplomatic relations, so the declaration was intended to externalize the break in relations between the two countries. Although Juan Manuel de Rosas was not anti-Peruvian, since he would declare war on Santa Cruz and his supporters, but not on the Peruvian states, it can be considered an episode of anti-Peruvianism in the history of Argentina, since the concern that the federal caudillo would have, in front of the power that Peru would be obtaining, in the Manifiesto de las razones que legitiman la Declaración de Guerra contra el gobierno del General Santa Cruz, Titulado Protector de la Confederación Perú-Boliviana [Manifesto of the reasons that legitimize the Declaration of War against the government of General Santa Cruz, Entitled Protector of the Peru-Bolivian Confederation].
==== Analysis ==== Analysis of FISH specimens is done by fluorescence microscopy by a clinical laboratory specialist in cytogenetics. For oncology, generally, a large number of interphase cells are scored in order to rule out low-level residual disease, generally between 200 and 1,000 cells are counted and scored. For congenital problems usually 20 metaphase cells are scored.
Klaus H. Hofmann (February 21, 1911 – December 25, 1995) was an American biological chemist and medical researcher. The New York Times called Hofmann an "expert on synthesis of body compounds". His career was highlighted by synthesis of a prototype birth control pill, isolation and structural characterization of biotin (vitamin H), determination of the lysine specificity of the pancreatic protease trypsin (an attribute that made it the enzyme of first choice in protein sequence determinations), the first chemical synthesis of a fully biologically-active portion of the peptide hormone (adrenocorticotopic hormone - ACTH), and structure-function studies on ribonuclease (RNase).
==== Adverse effect ==== Benzodiazepines lead to central nervous system depression, resulting in common adverse effects like drowsiness, oversedation, light-headedness. Memory impairment can be a common adverse effect especially in elderly, hypersalivation, ataxia, slurred speech, psychomotor effects.
Sources: en.wikipedia.org
Tensions between Portuguese and Brazilians increased and the Portuguese Cortes, guided by the new political regime imposed by the Liberal Revolution, tried to re-establish Brazil as a colony. The Brazilians refused to yield, and Prince Pedro decided to side with them, declaring the country's independence from Portugal on 7 September 1822. A month later, Prince Pedro was proclaimed the first Emperor of Brazil, with the royal title of Dom Pedro I, resulting in the founding of the Empire of Brazil. The Brazilian War of Independence, which had already begun along this process, spread through the northern, northeastern regions and in the Cisplatina province. The last Portuguese soldiers surrendered on 8 March 1824; Portugal officially recognized Brazilian independence on 29 August 1825. On 7 April 1831, worn down by years of administrative turmoil and political dissent with both liberals and conservatives, including an attempt of republican secession and unreconciled to the way that absolutists in Portugal had given in the succession of King John VI, Pedro I departed for Portugal to reclaim his daughter's crown after abdicating the Brazilian throne in favor of his five-year-old son and heir (Dom Pedro II).
=== Other countries === Austria: Word of the year (Austria), since 1999. The event is organised by the Society for Austrian German (GSÖD). Notable selections include the 52-letter word Bundespräsidentenstichwahlwiederholungsverschiebung (2016), and more recently, 'Elk Emil', in 2025. In Germany, a Wort des Jahres has been selected since 1972 (for the year 1971) by the Society of the German Language. In addition, an Unwort des Jahres (Un-word of the year or Most Unpleasant Word of the Year) has been nominated since 1991, for a word or phrase in public speech deemed insulting or socially inappropriate (such as "Überfremdung"). Similar selections are made each year since 1999 in Austria, 2002 in Liechtenstein, and 2003 in Switzerland. Since 2008, language publisher Langenscheidt supports a search for the German youth word of the year, which aims to find new words entering the language through the vernacular of young people. In addition, several German dialects have their own Wort des Jahres selection: de:Plattdeutsches Wort des Jahres, de:Wort des Jahres (Sachsen), and de:Wort des Jahres (Südtirol). In Denmark, the Word of the year has been selected by Mål og Mæle, a popular science language magazine, during 2006–2012 and since 2009 also by the Sproglaboratoriet radio program of the DR P1 radio channel in collaboration with Dansk Sprognævn (Danish Language Council). Japan has held an annual word of the year contest called the "New Word/Trendy Phrase Award" (Shingo ryūkōgo taishō) since 1984, sponsored by the Jiyu Kokuminsha publisher (by U-CAN since 2004).
== Production == Oleum is produced in the contact process, where sulfur is oxidized to sulfur trioxide which is subsequently dissolved in concentrated sulfuric acid. Sulfuric acid itself is regenerated by dilution of part of the oleum. The lead chamber process for sulfuric acid production was abandoned, partly because it could not produce sulfur trioxide or concentrated sulfuric acid directly due to corrosion of the lead, and absorption of NO2 gas. Until this process was made obsolete by the contact process, oleum had to be obtained through indirect methods. Historically, the biggest production of oleum came from the distillation of iron sulfates at Nordhausen, from which the historical name Nordhausen sulfuric acid is derived.
In 2002, Israel Prize In 2005, Louisa Gross Horwitz Prize In 2006, Wolf Prize in Chemistry along with George Feher. In 2006, The EMET Prize for Art, Science and Culture in Life Sciences, along with Professor Peretz Lavie (Medicine) and Professor Eli Keshet (Biology) In 2007, Paul Ehrlich and Ludwig Darmstaedter Prize along with Harry Noller In 2008, the Albert Einstein World Award of Science for her pioneering contributions to protein biosynthesis in the field of ribosomal crystallography and her introduction of innovative techniques in cryo bio-crystallography. In 2009, the Nobel Prize in Chemistry (co-recipient with Thomas Steitz and Venkatraman Ramakrishnan). She was the first Israeli woman to be awarded a Nobel Prize. In 2010, Wilhelm Exner Medal In 2011, Marie Curie Medal awarded by the Polish Chemical Society In 2013 she became a member of the German Academy of Sciences Leopoldina. In 2015, she was awarded Honorary Doctorates from the University of Southern California, the De La Salle University, Manila/Philippines; the Joseph Fourier University, Grenoble/France; the Medical University of Lodz, Lodz/Poland; and the University of Warwick, UK. In 2018, Elizabeth Cabezas, President of the Ecuadorian National Assembly, presented Yonath with the Presea "Asamblea Nacional de la República del Ecuador, Dra. Matilde Hidalgo de Procel" (National Assembly of Ecuador Dr. Matilde Hidalgo de Procel Medal) for scientific merit.
Sources: en.wikipedia.org
According to the International Society for Plastination, the Epoxy E 12 procedure is used "for thin, transparent, and firm body and organ slices", while the Polyester P 35 (P 40) preserves "semitransparent and firm brain slices". Samples are prepared for fixation through the first method by deep freezing, while the second method works best following 4–6 weeks of preparation in a formaldehyde mixture.
This procedure can induce ovulation, typically leads to a single pregnancy, but other risks may be higher compared to medication. The procedure might lead to lower chance of live births compared to medication alone. Ovarian wedge resection is no longer used as much due to complications such as adhesions and the presence of frequently effective medications. As a final treatment option, in vitro fertilisation (IVF) can be considered. IVF does increase the risk of ovarian hyperstimulation syndrome. Using a 'freeze all' strategy makes it easier to transfer a single embryo and provides time for the ovaries to recover from hyperstimulation. A less effective alternative, but with much lower risks of ovarian hyperstimulation syndrome, is in vitro maturation instead of full IVF. This option avoids high-dose gonadotropin therapy.
Skin hydration and surface lipids, on the other hand, did not significantly change with topical progesterone. These findings suggest that progesterone, like estrogen, also has beneficial effects on the skin and may be independently protective against skin aging.
Sources: en.wikipedia.org
PT-141 was the development code used for bremelanotide during its preclinical and early clinical programme. The peptide is now generally referred to by its international nonproprietary name.
The two compounds share the same cyclic core and are both non-selective melanocortin agonists. They differ chiefly at the C-terminus, where bremelanotide carries a free carboxylic acid and melanotan II a terminal amide.
Receptor binding profiles are well characterised in vitro, but the downstream pathway linking MC4R activation to behavioural effects is not fully mapped. Several intermediate neural circuits have been proposed without definitive confirmation.
The code designates bremelanotide, a cyclic heptapeptide melanocortin receptor agonist. It served as an internal research identifier before the compound entered formal clinical development. The code and the generic name refer to the same molecule.